Literature DB >> 17546847

ZFP36: a promising candidate gene for obesity-related metabolic complications identified by converging genomics.

Luigi Bouchard1, André Tchernof, Yves Deshaies, Simon Marceau, Odette Lescelleur, Simon Biron, Marie-Claude Vohl.   

Abstract

BACKGROUND: Few genes have been associated with the metabolic syndrome (MS), although its genetic component is well accepted. The aim of this study was to compare the adipose tissue gene expression profiles of obese men with and without the MS and to apply an integrative genomic approach to propose new candidate genes.
METHODS: Affymetrix HG-U133 plus 2 arrays have been used for expression profiling of omental adipose tissue of non-diabetic obese men with (n=7) and without (n=7) the MS, as defined by the NCEP-ATPIII, that undergo a bariatric operation.
RESULTS: Omentum expresses a total of 23 055 transcripts. Overall, 489 genes were differentially expressed between the two groups. A total of 80 differentially expressed genes were located within a previously identified region of linkage. In this subset of genes, zinc finger protein 36 (ZFP36) gene has been identified as the most promising genetic target for the MS-based mean fold expression differences and on biological plausibility. 2 out of 5 identified ZFP36 gene polymorphisms have been genotyped in a cohort of 698 obese subjects. The minor allele of these polymorphisms was associated with a lower body weight in women (rs251864; P< or =0.01) and glucose level in men (c.1564_1565delTT; P<0.05). The haplogenotype was associated with plasma LDL-cholesterol levels in men and women (P< or =0.02), and weight in women (P< or =0.05). The haplogenotype was also associated with omental adipose tissue ZFP36 mRNA levels (n=83 women; P=0.02), and explained 10.1% of its variance.
CONCLUSION: These results suggest that converging genomics is helpful to prioritize MS-related candidate genes and that ZFP36 is a promising candidate gene for obesity-associated metabolic complications.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17546847     DOI: 10.1007/s11695-007-9067-5

Source DB:  PubMed          Journal:  Obes Surg        ISSN: 0960-8923            Impact factor:   3.479


  27 in total

1.  A new statistical method for haplotype reconstruction from population data.

Authors:  M Stephens; N J Smith; P Donnelly
Journal:  Am J Hum Genet       Date:  2001-03-09       Impact factor: 11.025

2.  Familial correlations in the Québec family study: cross-trait familial resemblance for body fat with plasma glucose and insulin.

Authors:  T Rice; A Nadeau; L Pérusse; C Bouchard; D C Rao
Journal:  Diabetologia       Date:  1996-11       Impact factor: 10.122

3.  Quantitative trait locus on 15q for a metabolic syndrome variable derived from factor analysis.

Authors:  Yohan Bossé; Jean-Pierre Després; Yvon C Chagnon; Treva Rice; D C Rao; Claude Bouchard; Louis Pérusse; Marie-Claude Vohl
Journal:  Obesity (Silver Spring)       Date:  2007-03       Impact factor: 5.002

Review 4.  Genetics and the metabolic syndrome.

Authors:  C Bouchard
Journal:  Int J Obes Relat Metab Disord       Date:  1995-05

5.  Prevalence of the metabolic syndrome among US adults: findings from the third National Health and Nutrition Examination Survey.

Authors:  Earl S Ford; Wayne H Giles; William H Dietz
Journal:  JAMA       Date:  2002-01-16       Impact factor: 56.272

6.  Identification of hypertension-related genes through an integrated genomic-transcriptomic approach.

Authors:  Chana Yagil; Norbert Hubner; Jan Monti; Herbert Schulz; Marina Sapojnikov; Friedrich C Luft; Detlev Ganten; Yoram Yagil
Journal:  Circ Res       Date:  2005-02-24       Impact factor: 17.367

7.  Prevalence of uncomplicated obesity in an Italian obese population.

Authors:  Gianluca Iacobellis; Maria Cristina Ribaudo; Alessandra Zappaterreno; Concetta Valeria Iannucci; Frida Leonetti
Journal:  Obes Res       Date:  2005-06

8.  Feedback inhibition of macrophage tumor necrosis factor-alpha production by tristetraprolin.

Authors:  E Carballo; W S Lai; P J Blackshear
Journal:  Science       Date:  1998-08-14       Impact factor: 47.728

9.  Whole genome expression profiling of advance stage papillary serous ovarian cancer reveals activated pathways.

Authors:  Howard Donninger; Tomas Bonome; Mike Radonovich; Cynthia A Pise-Masison; John Brady; Joanna H Shih; J Carl Barrett; Michael J Birrer
Journal:  Oncogene       Date:  2004-10-21       Impact factor: 9.867

10.  The PPAR-gamma P12A polymorphism modulates the relationship between dietary fat intake and components of the metabolic syndrome: results from the Québec Family Study.

Authors:  J Robitaille; J-P Després; L Pérusse; M-C Vohl
Journal:  Clin Genet       Date:  2003-02       Impact factor: 4.438

View more
  27 in total

1.  The mRNA-binding protein Zfp36 is upregulated by β-adrenergic stimulation and represses IL-6 production in 3T3-L1 adipocytes.

Authors:  Pavna K Brahma; Huanchun Zhang; Betsy S Murray; Feng-jue Shu; Neil Sidell; Emre Seli; Caleb B Kallen
Journal:  Obesity (Silver Spring)       Date:  2011-08-04       Impact factor: 5.002

2.  A polymorphism of the interferon-gamma-inducible protein 30 gene is associated with hyperglycemia in severely obese individuals.

Authors:  V Turcot; L Bouchard; G Faucher; A Tchernof; Y Deshaies; L Pérusse; P Marceau; F S Hould; S Lebel; Marie-Claude Vohl
Journal:  Hum Genet       Date:  2011-06-24       Impact factor: 4.132

3.  C/EBPβ mediates growth hormone-regulated expression of multiple target genes.

Authors:  Tracy X Cui; Grace Lin; Christopher R LaPensee; Anda-Alexandra Calinescu; Maanjot Rathore; Cale Streeter; Graciela Piwien-Pilipuk; Nathan Lanning; Hui Jin; Christin Carter-Su; Zhaohui S Qin; Jessica Schwartz
Journal:  Mol Endocrinol       Date:  2011-02-03

Review 4.  Genetics of metabolic syndrome.

Authors:  Tisha Joy; Piya Lahiry; Rebecca L Pollex; Robert A Hegele
Journal:  Curr Diab Rep       Date:  2008-04       Impact factor: 4.810

Review 5.  Phosphorylation site analysis of the anti-inflammatory and mRNA-destabilizing protein tristetraprolin.

Authors:  Heping Cao; Leesa J Deterding; Perry J Blackshear
Journal:  Expert Rev Proteomics       Date:  2007-12       Impact factor: 3.940

6.  mRNA-binding protein ZFP36 is expressed in atherosclerotic lesions and reduces inflammation in aortic endothelial cells.

Authors:  Huanchun Zhang; W Robert Taylor; Giji Joseph; Valentina Caracciolo; Donna M Gonzales; Neil Sidell; Emre Seli; Perry J Blackshear; Caleb B Kallen
Journal:  Arterioscler Thromb Vasc Biol       Date:  2013-04-04       Impact factor: 8.311

7.  Symposium on obesity and asthma - November 2, 2006.

Authors:  Louis-Philippe Boulet; Qutayba Hamid; Simon L Bacon; Céline Bergeron; Louis-Philippe Boulet; Yue Chen; Anne E Dixon; Pierre Ernst; Qutayba Hamid; Fernando Holguin; Charles G Irvin; R John Kimoff; Sushma Komakula; Catherine Laprise; Kim L Lavoie; Stephanie A Shore; Mihaela Teodorescu; Marie-Claude Vohl
Journal:  Can Respir J       Date:  2007 May-Jun       Impact factor: 2.409

Review 8.  Role of oxysterol-binding protein-related proteins in malignant human tumours.

Authors:  Hao Liu; Shuai Huang
Journal:  World J Clin Cases       Date:  2020-01-06       Impact factor: 1.337

9.  Production and characterization of ZFP36L1 antiserum against recombinant protein from Escherichia coli.

Authors:  Heping Cao; Rui Lin; Sanjukta Ghosh; Richard A Anderson; Joseph F Urban
Journal:  Biotechnol Prog       Date:  2008-02-27

10.  Quantitative evaluation of His-tag purification and immunoprecipitation of tristetraprolin and its mutant proteins from transfected human cells.

Authors:  Heping Cao; Rui Lin
Journal:  Biotechnol Prog       Date:  2009 Mar-Apr
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.